Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.

Niklas Worm Andersson,Emilia Myrup Thiesson,Ulrike Baum,Nicklas Pihlström,Jostein Starrfelt,Kristýna Faksová,Eero Poukka,Lars Christian Lund,Christian Holm Hansen,Mia Aakjær,Jesper Kjær,Catherine Cohet,Mathijs Goossens,Morten Andersen,Jesper Hallas,Hinta Meijerink,Rickard Ljung,Anders Hviid

BMJ (Clinical research ed.)（2023）

引用 3|浏览10

暂无评分

摘要

Heterologous booster schedules are associated with increased protection against severe, omicron related covid-19 outcomes compared with primary course schedules and homologous booster schedules.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要